Open-mkt buys · 90d
$98.2K
8 trades · 4 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$98.2K
Insiders on file
20
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Chappell Amy Suzon | Director | 3 | $3.1K | $0 | 2026-08-28 |
| Palumbo Joseph M | Chief Medical Officer | 13 | $20.9K | $0 | 2026-08-28 |
| KIM JOANNE WENDY | Chief Financial Officer | 16 | $21.7K | $0 | 2026-08-28 |
| Do Cuong V | President & CEO, Director | 33 | $81.1K | $0 | 2026-08-27 |
| Farag Kameel D. | Director | 1 | $0 | $0 | 2026-01-05 |
| Sherman Michael Edward | Director | 14 | $0 | $0 | 2026-01-05 |
| Lang James Paul | Director | 18 | $0 | $0 | 2026-01-05 |
| ROGICH SIGMUND | Director | 8 | $0 | $0 | 2026-01-05 |
| Hariri Robert J | Director | 6 | $0 | $0 | 2024-12-20 |
| BERMAN RICHARD J | Director | 14 | $0 | $198.7K | 2024-12-20 |
| GORLIN STEVE | Director | 17 | $435.4K | $154.0K | 2023-12-01 |
| Ahlem Clarence N. | EVP Neuroscience Product Dev. | 3 | $0 | $0 | 2023-02-16 |
| MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | 3 | $0 | $0 | 2023-02-16 |
| READING CHRISTOPHER | EVP Neuroscience R&D | 3 | $0 | $0 | 2023-02-16 |
| PEIZER TERREN S | Director, 10% Owner | 22 | $0 | $0 | 2022-11-23 |
| Adams Jonathan M | chief operating officer | 10 | $0 | $0 | 2022-02-02 |
| Sooch Mina | Director | 3 | $0 | $0 | 2019-01-02 |
| Kumar Hari | Director | 5 | $0 | $0 | 2019-01-02 |
| Anderson Julie G | Director | 4 | $0 | $0 | 2018-05-31 |
| WIELAND R RICHARD | interim CFO | 1 | $0 | $0 | 2017-10-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| KIM JOANNE WENDY | Chief Financial Officer | P Buy | 2026-08-28 | 2026-08-28 | 2,500 | $2.18 | $5.5K | 3,441 | SEC↗ |
| Chappell Amy Suzon | Director | P Buy | 2026-08-28 | 2026-08-28 | 727 | $2.16 | $1.6K | 727 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | P Buy | 2026-08-28 | 2026-08-28 | 4,843 | $2.16 | $10.5K | 6,036 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | P Buy | 2026-08-28 | 2026-08-28 | 4,843 | $2.16 | $10.5K | 6,036 | SEC↗ |
| Chappell Amy Suzon | Director | P Buy | 2026-08-28 | 2026-08-28 | 727 | $2.16 | $1.6K | 727 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | P Buy | 2026-08-28 | 2026-08-28 | 2,500 | $2.18 | $5.5K | 3,441 | SEC↗ |
| DO CUONG V | President & CEO | P Buy | 2026-08-27 | 2026-08-28 | 15,210 | $2.08 | $31.6K | 16,117 | SEC↗ |
| DO CUONG V | President & CEO, Director | P Buy | 2026-08-27 | 2026-08-28 | 15,210 | $2.08 | $31.6K | 16,117 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 330,500 | — | $0 | 330,500 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Chappell Amy Suzon | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Farag Kameel D. | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 341,100 | — | $0 | 341,100 | SEC↗ |
| DO CUONG V | President & CEO | A Award deriv | 2026-01-05 | 2026-01-09 | 665,300 | — | $0 | 665,300 | SEC↗ |
| ROGICH SIGMUND | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ROGICH SIGMUND | Director | A Award deriv | 2026-01-05 | 2026-01-09 | 141,100 | — | $0 | 141,100 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award deriv | 2026-01-05 | 2026-01-09 | 110,100 | — | $0 | 110,100 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | A Award deriv | 2026-01-05 | 2026-01-09 | 132,000 | — | $0 | 132,000 | SEC↗ |
| DO CUONG V | President & CEO | P Buy deriv | 2025-08-07 | 2025-08-13 | 5,000 | — | $0 | 5,050 | SEC↗ |
| DO CUONG V | President & CEO | P Buy | 2025-08-07 | 2025-08-13 | 5,000 | — | $0 | 9,992 | SEC↗ |
| DO CUONG V | President & CEO | A Award deriv | 2024-12-20 | 2025-01-07 | 104,502 | — | $0 | 104,502 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award deriv | 2024-12-20 | 2025-01-07 | 14,417 | — | $0 | 14,417 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | A Award deriv | 2024-12-20 | 2025-01-07 | 15,417 | — | $0 | 15,417 | SEC↗ |
| Hariri Robert J | Director | A Award deriv | 2024-12-20 | 2025-01-07 | 21,815 | — | $0 | 21,815 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2024-12-20 | 2025-01-07 | 22,690 | — | $0 | 22,690 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2024-12-20 | 2025-01-07 | 23,325 | — | $0 | 23,325 | SEC↗ |
| BERMAN RICHARD J | Director | A Award deriv | 2024-12-20 | 2025-01-07 | 23,155 | — | $0 | 23,155 | SEC↗ |
| ROGICH SIGMUND | Director | A Award deriv | 2024-12-20 | 2025-01-07 | 22,070 | — | $0 | 22,070 | SEC↗ |
| Hariri Robert J | Director | A Award deriv | 2024-11-20 | 2025-01-07 | 49,800 | — | $0 | 49,800 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2024-11-20 | 2025-01-07 | 61,600 | — | $0 | 61,600 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2024-11-20 | 2025-01-07 | 56,900 | — | $0 | 56,900 | SEC↗ |
| BERMAN RICHARD J | Director | A Award | 2024-11-20 | 2025-01-07 | 34,200 | — | $0 | 40,643 | SEC↗ |
| ROGICH SIGMUND | Director | A Award | 2024-11-20 | 2025-01-07 | 32,700 | — | $0 | 36,926 | SEC↗ |
| DO CUONG V | President & CEO | A Award deriv | 2024-06-24 | 2024-07-12 | 227,000 | — | $0 | 227,000 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award deriv | 2024-06-24 | 2024-07-12 | 99,000 | — | $0 | 99,000 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | A Award deriv | 2024-06-24 | 2024-07-12 | 156,000 | — | $0 | 156,000 | SEC↗ |
| DO CUONG V | President & CEO | F Tax w/h | 2024-06-24 | 2024-07-12 | 42,000 | $0.47 | $19.7K | 551,948 | SEC↗ |
| DO CUONG V | President & CEO | A Award | 2024-06-24 | 2024-07-12 | 168,000 | — | $0 | 593,948 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award | 2024-06-24 | 2024-07-12 | 73,000 | — | $0 | 112,196 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | F Tax w/h | 2024-06-24 | 2024-07-12 | 18,250 | $0.47 | $8.6K | 93,940 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | A Award | 2024-06-24 | 2024-07-12 | 116,000 | — | $0 | 148,196 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | F Tax w/h | 2024-06-24 | 2024-07-12 | 29,000 | $0.47 | $13.6K | 119,196 | SEC↗ |
| DO CUONG V | President & CEO | P Buy deriv | 2024-03-04 | 2024-03-06 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DO CUONG V | President & CEO | P Buy | 2024-03-04 | 2024-03-06 | 10,000 | — | $0 | 435,854 | SEC↗ |
| DO CUONG V | President & CEO | F Tax w/h | 2024-02-15 | 2024-07-12 | 4,953 | $1.18 | $5.8K | 425,948 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | F Tax w/h | 2024-02-15 | 2024-07-12 | 2,476 | $1.18 | $2.9K | 39,196 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | F Tax w/h | 2024-02-15 | 2024-07-12 | 2,476 | $1.18 | $2.9K | 32,196 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award | 2023-12-11 | 2023-12-13 | 5,000 | — | $0 | 44,148 | SEC↗ |
| GORLIN STEVE | Director | S Sale | 2023-12-01 | 2023-12-06 | 75,680 | $1.69 | $127.9K | 46,358 | SEC↗ |
| DO CUONG V | President & CEO | P Buy | 2023-11-30 | 2023-12-01 | 10,000 | $1.78 | $17.8K | 68,759 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2023-11-09 | 2023-12-06 | 89,750 | — | $0 | 89,750 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2023-11-09 | 2023-12-06 | 93,500 | — | $0 | 93,500 | SEC↗ |
| BERMAN RICHARD J | Director | A Award | 2023-11-09 | 2023-12-06 | 51,830 | — | $0 | 69,235 | SEC↗ |
| Hariri Robert J | Director | A Award | 2023-11-09 | 2023-12-06 | 42,254 | — | $0 | 42,254 | SEC↗ |
| ROGICH SIGMUND | Director | A Award | 2023-11-09 | 2023-12-06 | 42,254 | — | $0 | 42,254 | SEC↗ |
| GORLIN STEVE | Director | A Award | 2023-11-09 | 2023-12-06 | 46,358 | — | $0 | 122,038 | SEC↗ |
| GORLIN STEVE | Director | S Sale | 2023-09-05 | 2023-09-07 | 8,560 | $3.05 | $26.1K | 75,680 | SEC↗ |
| BERMAN RICHARD J | Director | S Sale | 2023-08-22 | 2023-08-24 | 10,805 | $3.50 | $37.8K | 16,789 | SEC↗ |
| DO CUONG V | CEO & President | A Award deriv | 2023-06-29 | 2023-07-03 | 175,000 | — | $0 | 175,000 | SEC↗ |
| DO CUONG V | CEO & President | A Award | 2023-06-29 | 2023-07-03 | 149,500 | — | $0 | 425,854 | SEC↗ |
| DO CUONG V | CEO & President | M Exercise deriv | 2023-06-21 | 2023-06-26 | 41,506 | — | $0 | 83,014 | SEC↗ |
| DO CUONG V | CEO & President | M Exercise | 2023-06-21 | 2023-06-26 | 41,506 | — | $0 | 271,401 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | A Award deriv | 2023-06-07 | 2023-07-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award deriv | 2023-06-07 | 2023-07-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BERMAN RICHARD J | Director | S Sale | 2023-06-07 | 2023-06-15 | 5,984 | $5.81 | $34.8K | 23,210 | SEC↗ |
| BERMAN RICHARD J | Director | S Sale | 2023-05-22 | 2023-06-15 | 5,000 | $6.50 | $32.5K | 29,194 | SEC↗ |
| BERMAN RICHARD J | Director | S Sale | 2023-03-28 | 2023-04-06 | 2,613 | $8.52 | $22.3K | 34,194 | SEC↗ |
| BERMAN RICHARD J | Director | S Sale | 2023-03-28 | 2023-04-06 | 5,000 | $8.52 | $42.6K | 36,807 | SEC↗ |
| BERMAN RICHARD J | Director | S Sale | 2023-03-27 | 2023-04-06 | 3,371 | $8.52 | $28.7K | 41,807 | SEC↗ |
| DO CUONG V | President & CEO | F Tax w/h | 2023-02-16 | 2024-07-12 | 4,953 | $5.51 | $27.3K | 430,901 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | F Tax w/h | 2023-02-16 | 2024-07-12 | 2,476 | $5.51 | $13.6K | 41,672 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | F Tax w/h | 2023-02-16 | 2024-07-12 | 2,476 | $5.51 | $13.6K | 34,672 | SEC↗ |
| MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | F Tax w/h | 2023-02-16 | 2023-02-22 | 2,476 | $6.12 | $15.2K | 47,841 | SEC↗ |
| READING CHRISTOPHER | EVP Neuroscience R&D | F Tax w/h | 2023-02-16 | 2023-02-22 | 2,476 | $6.12 | $15.2K | 37,148 | SEC↗ |
| Ahlem Clarence N. | EVP Neuroscience Product Dev | F Tax w/h | 2023-02-16 | 2023-02-22 | 2,476 | $6.12 | $15.2K | 37,148 | SEC↗ |
| DO CUONG V | CEO & President | F Tax w/h | 2023-02-16 | 2023-02-22 | 4,953 | $6.12 | $30.3K | 229,895 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | F Tax w/h | 2023-02-16 | 2023-02-22 | 2,476 | $6.12 | $15.2K | 39,148 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | F Tax w/h | 2023-02-16 | 2023-02-22 | 2,476 | $6.12 | $15.2K | 37,148 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award deriv | 2022-11-23 | 2023-01-18 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2022-11-23 | 2023-01-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ROGICH SIGMUND | Director | A Award deriv | 2022-11-23 | 2023-01-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | A Award | 2022-11-23 | 2023-01-18 | 39,624 | — | $0 | 50,317 | SEC↗ |
| DO CUONG V | CEO & President | A Award | 2022-11-23 | 2023-01-18 | 79,248 | — | $0 | 234,848 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award | 2022-11-23 | 2023-01-18 | 39,624 | — | $0 | 41,624 | SEC↗ |
| BERMAN RICHARD J | Director | A Award | 2022-11-23 | 2023-01-18 | 43,578 | — | $0 | 45,178 | SEC↗ |
| Ahlem Clarence N. | EVP Neuroscience Product Dev | A Award | 2022-11-23 | 2023-01-18 | 39,624 | — | $0 | 39,624 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | A Award | 2022-11-23 | 2023-01-18 | 39,624 | — | $0 | 39,624 | SEC↗ |
| Hariri Robert J | Director | A Award | 2022-11-23 | 2023-01-18 | 34,240 | — | $0 | 34,240 | SEC↗ |
| READING CHRISTOPHER | EVP Neuroscience R&D | A Award | 2022-11-23 | 2023-01-18 | 39,624 | — | $0 | 39,624 | SEC↗ |
| Lang James Paul | Director | A Award | 2022-11-23 | 2023-01-18 | 43,578 | — | $0 | 68,622 | SEC↗ |
| GORLIN STEVE | Director | A Award | 2022-11-23 | 2023-01-18 | 34,240 | — | $0 | 84,240 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award deriv | 2022-08-15 | 2022-08-16 | 7,272,728 | — | $0 | 7,272,728 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2022-08-15 | 2022-08-16 | 3,636,364 | $1.65 | $6.00M | 23,166,210 | SEC↗ |
| DO CUONG V | President & CEO | A Award deriv | 2022-06-21 | 2022-07-07 | 124,520 | — | $0 | 124,520 | SEC↗ |
| DO CUONG V | President & CEO | A Award deriv | 2022-06-21 | 2022-07-07 | 124,520 | — | $0 | 124,520 | SEC↗ |
| Hariri Robert J | Director | A Award deriv | 2022-04-05 | 2022-04-20 | 122,250 | — | $0 | 122,250 | SEC↗ |
| BERMAN RICHARD J | Director | A Award deriv | 2022-04-05 | 2022-04-20 | 129,050 | — | $0 | 129,050 | SEC↗ |
| GORLIN STEVE | Director | A Award deriv | 2022-04-05 | 2022-04-20 | 122,250 | — | $0 | 122,250 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2022-04-05 | 2022-04-20 | 130,150 | — | $0 | 130,150 | SEC↗ |
| ROGICH SIGMUND | Director | A Award deriv | 2022-04-05 | 2022-04-21 | 123,400 | — | $0 | 123,400 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2022-04-05 | 2022-04-25 | 127,900 | — | $0 | 127,900 | SEC↗ |
| Adams Jonathan M | EVP Liver Cirrhosis Programs | G Gift | 2022-02-02 | 2022-02-16 | 1,000 | — | $0 | 48,630 | SEC↗ |
| Palumbo Joseph M | Chief Medical Officer | A Award deriv | 2022-02-01 | 2022-02-17 | 124,167 | — | $0 | 124,167 | SEC↗ |
| DO CUONG V | President & CEO | A Award | 2021-12-31 | 2022-01-25 | 21,710 | — | $0 | 58,759 | SEC↗ |
| KIM JOANNE WENDY | CFO | P Buy | 2021-12-07 | 2021-12-09 | 2,000 | $5.40 | $10.8K | 2,000 | SEC↗ |
| READING CHRISTOPHER | EVP Neuroscience R&D | A Award deriv | 2021-08-20 | 2021-10-08 | 124,167 | — | $0 | 124,167 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award deriv | 2021-08-20 | 2021-09-16 | 124,167 | — | $0 | 124,167 | SEC↗ |
| Adams Jonathan M | EVP Liver Cirrhosis Programs | A Award deriv | 2021-08-20 | 2021-09-16 | 124,167 | — | $0 | 124,167 | SEC↗ |
| MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | A Award deriv | 2021-08-20 | 2021-09-16 | 124,167 | — | $0 | 124,167 | SEC↗ |
| Do Cuong V | CEO & President | A Award deriv | 2021-08-20 | 2021-09-16 | 745,000 | — | $0 | 745,000 | SEC↗ |
| Ahlem Clarence N. | EVP Neuroscience Product Dev | A Award deriv | 2021-08-20 | 2021-09-28 | 124,167 | — | $0 | 124,167 | SEC↗ |
| Adams Jonathan M | EVP Liver Cirrhosis Programs | G Gift | 2021-06-16 | 2021-10-29 | 10,000 | — | $0 | 49,630 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2021-06-10 | 2022-08-26 | 8,361,308 | — | $0 | 19,529,846 | SEC↗ |
| Hariri Robert J | Director | A Award deriv | 2020-12-18 | 2021-09-28 | 95,900 | — | $0 | 95,900 | SEC↗ |
| BERMAN RICHARD J | Director | A Award deriv | 2020-12-18 | 2021-09-29 | 102,500 | — | $0 | 102,500 | SEC↗ |
| Do Cuong V | Director | A Award deriv | 2020-12-18 | 2021-03-04 | 97,500 | $13.91 | $1.36M | 171,366 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2020-12-18 | 2021-03-04 | 99,000 | $13.91 | $1.38M | 120,988 | SEC↗ |
| ROGICH SIGMUND | Director | A Award deriv | 2020-12-18 | 2021-03-04 | 97,300 | $13.91 | $1.35M | 97,300 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2020-12-18 | 2021-03-04 | 103,100 | $13.91 | $1.43M | 119,906 | SEC↗ |
| GORLIN STEVE | Director | A Award deriv | 2020-12-18 | 2021-03-05 | 96,300 | $13.91 | $1.34M | 96,300 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-11-03 | 2020-12-15 | 2,430 | $7.95 | $19.3K | 45,100 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-30 | 2020-12-15 | 2,570 | $7.97 | $20.5K | 42,670 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-21 | 2020-10-22 | 5,000 | $9.19 | $46.0K | 40,100 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-15 | 2020-10-19 | 100 | $10.27 | $1.0K | 20,100 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-15 | 2020-10-19 | 4,000 | $10.19 | $40.8K | 25,100 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-15 | 2020-10-19 | 1,000 | $10.18 | $10.2K | 21,100 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-15 | 2020-10-19 | 5,000 | $10.01 | $50.0K | 35,100 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-15 | 2020-10-19 | 5,000 | $10.10 | $50.5K | 30,100 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2020-10-13 | 2020-10-21 | 800 | $9.90 | $7.9K | 16,806 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-09 | 2020-10-14 | 282 | $9.61 | $2.7K | 20,000 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-10-07 | 2020-10-14 | 4,718 | $9.42 | $44.4K | 19,718 | SEC↗ |
| KIM JOANNE WENDY | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-21 | 800 | $9.54 | $7.6K | 2,400 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | M Exercise deriv | 2020-09-22 | 2022-08-26 | 0 | — | $0 | 0 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | M Exercise deriv | 2020-09-22 | 2022-08-26 | 0 | — | $0 | 0 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | D To issuer deriv | 2020-09-22 | 2022-08-26 | 299,750 | — | $0 | 0 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | M Exercise | 2020-09-22 | 2022-08-26 | 1,549,750 | — | $0 | 11,168,538 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2020-09-22 | 2022-08-26 | 5,359,832 | — | $0 | 9,618,788 | SEC↗ |
| GORLIN STEVE | Director | P Buy | 2020-09-22 | 2020-10-14 | 15,000 | $10.00 | $150.0K | 15,000 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award deriv | 2020-07-13 | 2022-08-26 | 1,250,000 | — | $0 | 0 | SEC↗ |
| BERMAN RICHARD J | Director | A Award deriv | 2020-01-19 | 2021-09-29 | 800 | — | $0 | 800 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2020-01-02 | 2022-08-26 | 1,600 | — | $0 | 4,258,956 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2020-01-02 | 2022-08-26 | 4,422 | — | $0 | 4,257,356 | SEC↗ |
| BERMAN RICHARD J | Director | A Award | 2020-01-02 | 2021-09-29 | 1,600 | — | $0 | 1,600 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award deriv | 2019-09-24 | 2022-08-26 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award deriv | 2019-09-24 | 2022-08-26 | 299,750 | — | $0 | 299,750 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2019-09-24 | 2022-08-26 | 1,125,000 | — | $0 | 4,252,934 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | D To issuer deriv | 2019-06-24 | 2022-08-26 | 1,713,331 | — | $0 | 0 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2019-06-24 | 2022-08-26 | 1,526,334 | $45.00 | $68.69M | 3,127,934 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | A Award | 2019-01-02 | 2022-08-26 | 1,600 | — | $0 | 1,601,600 | SEC↗ |
| Lang James Paul | Director | A Award | 2019-01-02 | 2019-02-05 | 200,000 | $0.04 | $8.0K | 450,000 | SEC↗ |
| Sooch Mina | Director | A Award | 2019-01-02 | 2019-02-05 | 200,000 | $0.04 | $8.0K | 813,636 | SEC↗ |
| Do Cuong V | Director | A Award | 2019-01-02 | 2019-02-05 | 200,000 | $0.04 | $8.0K | 2,871,354 | SEC↗ |
| Sherman Michael Edward | Director | A Award | 2019-01-02 | 2019-02-05 | 200,000 | $0.04 | $8.0K | 718,181 | SEC↗ |
| Adams Jonathan M | Chief Operating Officer | A Award | 2019-01-02 | 2019-02-05 | 200,000 | $0.04 | $8.0K | 6,303,521 | SEC↗ |
| Kumar Hari | Director | A Award | 2019-01-02 | 2019-03-13 | 200,000 | $0.04 | $8.0K | 727,272 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | C Conversion | 2018-08-13 | 2022-08-26 | 1,600,000 | — | $0 | 1,600,000 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | C Conversion deriv | 2018-08-03 | 2022-08-26 | 1,600,000 | — | $0 | 0 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | P Buy deriv | 2018-07-03 | 2022-08-26 | 1,713,331 | — | $0 | 1,713,331 | SEC↗ |
| PEIZER TERREN S | Director, 10% Owner | P Buy deriv | 2018-07-03 | 2022-08-26 | 1,600,000 | — | $0 | 1,600,000 | SEC↗ |
| Do Cuong V | Director | A Award deriv | 2018-07-03 | 2018-11-01 | 8,666,666 | $0.02 | $173.3K | 9,033,333 | SEC↗ |
| Adams Jonathan M | Chief Operating Officer | A Award deriv | 2018-07-03 | 2018-11-01 | 1,000,000 | $0.02 | $20.0K | 4,022,727 | SEC↗ |
| Lang James Paul | Director | A Award | 2018-07-03 | 2018-11-01 | 20,000 | $1.50 | $30.0K | 20,000 | SEC↗ |
| Do Cuong V | Director | A Award | 2018-07-03 | 2018-11-01 | 86,666 | $1.50 | $130.0K | 86,666 | SEC↗ |
| Adams Jonathan M | Chief Operating Officer | A Award | 2018-07-03 | 2018-11-01 | 10,000 | $1.50 | $15.0K | 10,000 | SEC↗ |
| Sherman Michael Edward | Director | A Award deriv | 2018-07-03 | 2018-08-01 | 1,666,000 | $0.02 | $33.3K | 1,666,000 | SEC↗ |
| Sherman Michael Edward | Director | A Award | 2018-07-03 | 2018-08-01 | 16,666 | $1.50 | $25.0K | 16,666 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2018-07-02 | 2018-11-01 | 2,000,000 | $0.02 | $40.0K | 2,548,485 | SEC↗ |
| Kumar Hari | Director | A Award | 2018-06-15 | 2019-03-13 | 100,000 | $0.02 | $2.0K | 527,272 | SEC↗ |
| Anderson Julie G | Director | A Award | 2018-05-31 | 2018-08-09 | 68,500 | $0.02 | $1.4K | 368,500 | SEC↗ |
| Sherman Michael Edward | Director | A Award | 2018-05-15 | 2018-08-01 | 250,000 | $0.02 | $5.0K | 518,181 | SEC↗ |
| Sooch Mina | Director | A Award | 2018-04-30 | 2018-08-14 | 150,000 | $0.02 | $3.0K | 613,636 | SEC↗ |
| Anderson Julie G | Director | A Award deriv | 2018-03-14 | 2018-08-09 | 100,000 | $0.06 | $6.0K | 200,000 | SEC↗ |
| Do Cuong V | Director | A Award deriv | 2018-01-19 | 2018-08-14 | 100,000 | $0.10 | $10.0K | 366,667 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2018-01-19 | 2018-08-15 | 100,000 | $0.10 | $10.0K | 548,485 | SEC↗ |
| Do Cuong V | Director | A Award deriv | 2018-01-08 | 2018-08-14 | 166,667 | $0.15 | $25.0K | 266,667 | SEC↗ |
| Do Cuong V | Director | D To issuer | 2018-01-08 | 2018-08-14 | 166,667 | $0.15 | $25.0K | 3,038,021 | SEC↗ |
| Kumar Hari | Director | A Award | 2018-01-02 | 2019-03-13 | 200,000 | $0.15 | $30.0K | 427,272 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2018-01-02 | 2018-08-15 | 166,667 | $0.15 | $25.0K | 448,485 | SEC↗ |
| Sherman Michael Edward | Director | A Award | 2018-01-02 | 2018-08-01 | 200,000 | $0.15 | $30.0K | 268,181 | SEC↗ |
| Adams Jonathan M | chief operating officer | A Award | 2018-01-02 | 2018-08-09 | 200,000 | — | $0 | 6,103,521 | SEC↗ |
| Anderson Julie G | Director | A Award | 2018-01-02 | 2018-08-09 | 200,000 | $0.15 | $30.0K | 300,000 | SEC↗ |
| Do Cuong V | Director | A Award | 2018-01-02 | 2018-08-14 | 200,000 | $0.15 | $30.0K | 2,871,354 | SEC↗ |
| Sooch Mina | Director | A Award | 2018-01-02 | 2018-08-14 | 200,000 | $0.15 | $30.0K | 463,636 | SEC↗ |
| Lang James Paul | Director | A Award | 2018-01-02 | 2018-08-15 | 166,667 | $0.15 | $25.0K | 530,303 | SEC↗ |
| Lang James Paul | Director | A Award | 2018-01-02 | 2018-08-15 | 200,000 | $0.15 | $30.0K | 730,303 | SEC↗ |
| WIELAND R RICHARD | interim CFO | A Award deriv | 2017-10-25 | 2018-09-04 | 150,000 | $0.21 | $31.5K | 250,000 | SEC↗ |
| Kumar Hari | Director | A Award deriv | 2017-08-14 | 2019-03-13 | 45,455 | $0.60 | $27.3K | 213,637 | SEC↗ |
| Kumar Hari | Director | A Award | 2017-08-14 | 2019-03-13 | 90,908 | $0.22 | $20.0K | 227,272 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2017-07-28 | 2018-08-15 | 56,818 | $0.60 | $34.1K | 281,818 | SEC↗ |
| Lang James Paul | Director | A Award | 2017-07-28 | 2018-08-15 | 113,636 | $0.22 | $25.0K | 363,636 | SEC↗ |
| Adams Jonathan M | chief operating officer | A Award deriv | 2017-07-27 | 2018-08-09 | 22,727 | $0.60 | $13.6K | 3,022,727 | SEC↗ |
| Adams Jonathan M | chief operating officer | A Award | 2017-07-27 | 2018-08-09 | 45,454 | $0.22 | $10.0K | 5,903,521 | SEC↗ |
| Anderson Julie G | Director | A Award deriv | 2017-03-15 | 2018-08-09 | 50,000 | $0.50 | $25.0K | 50,000 | SEC↗ |
| Do Cuong V | Director | A Award deriv | 2016-12-08 | 2018-08-14 | 100,000 | $0.21 | $21.0K | 100,000 | SEC↗ |
| Lang James Paul | Director | A Award deriv | 2016-12-08 | 2018-08-15 | 100,000 | $0.21 | $21.0K | 225,000 | SEC↗ |
| Adams Jonathan M | chief operating officer | J Other | 2016-04-11 | 2018-08-09 | 310,000 | — | $0 | 5,858,067 | SEC↗ |